0

Recent Updates and Future Perspectives About Amygdalin as a Potential Anticancer Agent: A Review

Jiamin Shi, Qianqian Chen, Meng Xu, Qing Xia, Tiansheng Zheng, Junliang Teng, Ming Li, Lihong Fan

Cancer Med. 2019 Jun;8(6):3004-3011.

PMID: 31066207

Abstract:

The overall incidence of cancer is increasing in recent years. Despite advances in various comprehensive treatments, the mortality of advanced malignant tumors remains at a high level. Numerous pharmacological studies have confirmed that many Chinese herbal medicines possess remarkable antitumor activities. Amygdalin, mainly existing in bitter almond, is reported to have antitumor properties in addition to the antioxidative, antibacterial, anti-inflammatory and immunoregulatory activities. This article summarizes the structural characteristics of amygdalin, its antitumor mechanisms, and recent progress and achievement in the research of amygdalin, hoping that it could provide theoretical clues for exploring the clinical value of amygdalin against tumors. Amygdalin is known to have an antitumor effect in solid tumors such as lung cancer, bladder cancer and renal cell carcinoma by affecting cell cycle, inducing apoptosis and cytotoxicity, and regulating immune function. Further research is needed to elucidate the pharmacological mechanisms of amygdalin in terms of the optimal dosage, the feasibility of combined use of amygdalin with other antitumor drugs, and even artificial synthesis of the active components in amygdalin, for the sake of enhancing its antitumor activities and reducing its adverse effects for clinical use.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP29883156 Amygdalin Amygdalin 29883-15-6 Price
qrcode